Service
MAJOR BREAKTHROUGH RESEARCH! In the in-vitro cytokine laboratory, we discovered that women with triple negative breast cancer after full treatment with Herceptin®, chemotherapy, radiation and surgery still had evidence of inflammation.
We found that specific natural hormones reduced these interleukin to normal range. The patients were treated with Vag 4:1 cream® for one-year and the LabCorp: inflammation
TO REGISTER for this retrospective chart study, call 1.877.Oxytocin. We suggest you get the two LabCorp panels and the Artificial Intelligence-beta algorithm will make suggestions. Consultations with Dr. Lichten’s team will be available as a fee-for-service.
673ed77cd5373
New Breakthrough Diagnosing Cancer
673ed77cd5680
THE RESEARCH: CANCER shows inflammation so when all treatments have been completed and the in-vitro cytokine laboratory still shows inflammation, there must be microscopic metastases or another source.
THE RESEARCH: CANCER shows inflammation so when all treatments have been completed and the in-vitro cytokine laboratory still shows inflammation, there must be microscopic metastases or another source.